REFERENCES
1. Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline - updated October 2017. Endoscopy 2018;50:910-30.
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
3. Lang L, Chemmalakuzhy R, Shay C, Teng Y. PFKP signaling at a glance: an emerging mediator of cancer cell metabolism. In: Guest PC, editor. Reviews on biomarker studies of metabolic and metabolism-related disorders. Cham: Springer International Publishing; 2019. pp. 243-58.
4. Lee JH, Liu R, Li J, et al. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. Nat Commun 2017;8:949.
5. Lee SY, Jin CC, Choi JE, et al. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer. Sci Rep 2016;6:35603.
6. Shen J, Jin Z, Lv H, et al. PFKP is highly expressed in lung cancer and regulates glucose metabolism. Cell Oncol 2020;43:617-29.
7. Wang F, Li L, Zhang Z. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non-small cell lung cancer. Mol Med Rep 2021;23:74.
8. Zhang CZ, Chen GG, Lai PB. Transcription factor ZBP-89 in cancer growth and apoptosis. Biochim Biophys Acta 2010;1806:36-41.
9. Zou ZV, Gul N, Lindberg M, et al. Genomic profiling of the transcription factor Zfp148 and its impact on the p53 pathway. Sci Rep 2020;10:14156.
10. Nilton A, Sayin VI, Zou ZV, et al. Targeting Zfp148 activates p53 and reduces tumor initiation in the gut. Oncotarget 2016;7:56183-92.
11. Essien BE, Sundaresan S, Ocadiz-Ruiz R, et al. Transcription factor ZBP-89 drives a feedforward loop of β-catenin expression in colorectal cancer. Cancer Res 2016;76:6877-87.
12. Liu L, Wang Y, Bai R, Yang K, Tian Z. MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation. Oncogenesis 2017;6:e318.
13. Zhou Z, Qin J, Song C, et al. circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. J Cancer 2023;14:2574-84.
14. Wang S, Park SH, Lim JS, Park YY, Du L, Lee JH. Phosphofructokinase 1 platelet isoform induces PD-L1 expression to promote glioblastoma immune evasion. Genes Genomics 2022;44:1509-17.
15. Miller M, Hanna N. Advances in systemic therapy for non-small cell lung cancer. BMJ 2021;375:n2363.
17. Liu P, Wang Z, Ou X, et al. The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition. Mol Cancer 2022;21:198.
18. Yu Z, Tang H, Chen S, et al. Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy. Drug Resist Updat 2022;67:100915.
19. Zou Y, Ye F, Kong Y, et al. The single-cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer. Adv Sci 2023;10:e2203699.
20. Sha X, Wang K, Wang F, Zhang C, Yang L, Zhu X. Silencing PFKP restrains the stemness of hepatocellular carcinoma cells. Exp Cell Res 2021;407:112789.
21. Chen G, Liu H, Zhang Y, et al. Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma. Exp Cell Res 2018;370:46-57.
22. Wang Y, Mei Q, Ai YQ, et al. Identification of lung cancer oncogenes based on the mRNA expression and single nucleotide polymorphism profile data. Neoplasma 2015;62:966-73.
23. Vidoni C, Ferraresi A, Vallino L, et al. Glycolysis inhibition of autophagy drives malignancy in ovarian cancer: exacerbation by IL-6 and attenuation by resveratrol. Int J Mol Sci 2023;24:1723.
24. Savio M, Ferraresi A, Corpina C, et al. Resveratrol and its analogue 4,4′-dihydroxy-trans-stilbene inhibit lewis lung carcinoma growth in vivo through apoptosis, autophagy and modulation of the tumour microenvironment in a murine model. Biomedicines 2022;10:1784.
25. Chen J, Zou L, Lu G, et al. PFKP alleviates glucose starvation-induced metabolic stress in lung cancer cells via AMPK-ACC2 dependent fatty acid oxidation. Cell Discov 2022;8:52.
26. Zhang L, Ke J, Min S, et al. Hyperbaric oxygen therapy represses the warburg effect and epithelial-mesenchymal transition in hypoxic NSCLC cells via the HIF-1α/PFKP axis. Front Oncol 2021;11:691762.
27. Yan SM, Wu HN, He F, et al. High expression of zinc-binding protein-89 predicts decreased survival in esophageal squamous cell cancer. Ann Thorac Surg 2014;97:1966-73.
28. Gao X, Ma C, Sun X, et al. Upregulation of ZNF148 in SDHB-deficient gastrointestinal stromal tumor potentiates Forkhead box M1-mediated transcription and promotes tumor cell invasion. Cancer Sci 2020;111:1266-78.
29. Cai MY, Luo RZ, Li YH, et al. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma. Biochem Biophys Res Commun 2012;426:636-42.
30. Gao X, Qin S, Wu Y, et al. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Invest 2021;131:e143119.
31. Huang X, Xie X, Wang H, et al. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res 2017;36:129.
